# Aptus Pharma Ltd (APPL) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹225.15 Day Change: -0.43% 52W High: ₹185.8 52W Low: ₹32.32 Market Cap: ₹317 Cr ## Valuation P/E: 59.49 P/B: 5.41 EPS: ₹3.11 Book Value: ₹34.2 Dividend Yield: 0% ## Returns 1Y Return: 0% ## Profitability ROE: 71.43% ROCE: 0% Debt/Equity: 0 Revenue Growth: 0% Profit Growth: 0% EBITDA Margin: 0% Operating Margin: 0% ## About Aptus Pharma Ltd is a Medical Distribution company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Medical Distribution Sub Industry: Unknown ## Business Model Overview: Aptus Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Distribution. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations, 2015 - Announcement: Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011 - BSE Filing: Disclosure As Per Regulation 7(2) Of SEBI (PIT) Regulations, 2015 ## Access Current tier: anonymous More history: Register free to see 1 more year. ## Data Freshness Quote Updated: 2026-06-04T09:15:22.270Z Price History Updated: 2026-06-08T12:00:28.486Z Latest Price History Date: 2026-06-04 Technicals Updated: 2026-06-08T12:00:28.486Z Quant Updated: 2026-06-08T12:00:28.486Z Sentiment Updated: 2026-06-08T12:00:28.486Z Financials Status: current Financials Updated: 2026-05-18T11:30:01.208Z Financials Last Attempt: 2026-05-18T11:30:01.208Z Financials Provider Tried: database Latest P&L Period: FY 2026 Latest Balance Sheet Period: FY 2026 Latest Cash Flow Period: FY 2026 ## P&L (FY 2023) Revenue: ₹14 Cr Operating Profit: ₹0 Cr (OPM 3.15%) Net Profit: ₹0 Cr Tax: ₹0 Cr ## Annual P&L History FY 2023: Rev ₹14Cr | PAT ₹0Cr | OPM 3.15% FY 2024: Rev ₹18Cr | PAT ₹1Cr | OPM 7.46% FY 2025: Rev ₹25Cr | PAT ₹3Cr | OPM 18.66% ## Balance Sheet (FY 2023) Total Assets: ₹6 Cr Total Liabilities: ₹5 Cr Borrowings: ₹2 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% --- Source: rupiya.io/stocks/appl Disclaimer: For research and education only. Not investment advice.